Virtus LifeSci Biotech Cl... (BBC)
NYSEArca: BBC
· Prix en temps réel · USD
53.26
+0.39 (0.74%)
À la clôture : Aug 17, 2026, 3:58 PM
Virtus LifeSci Biotech Clinical Trials ETF (BBC) ETF Price, Holdings & Analysis
0.74% (1D)
| Bid | 0 |
| Capitalisation boursière | n/a |
| AUM | 46.39M |
| NAV | 52.95 |
| Bêta | 1.26 |
| EPS (ttm) | n / A |
| Rapport PE (ttm) | n / A |
| Parts en circulation | n / A |
| Date de création | Dec 16, 2014 |
| Ask | 0 |
| Volume | 8,499 |
| Moy. Volume (20D) | 23,685 |
| Ouverture | 52.60 |
| Clôture précédente | 52.87 |
| Fourchette du jour | 52.53 - 53.26 |
| Intervalle de 52 semaines | 21.83 - 54.95 |
| Positions | n / A |
| Ratio de frais | 0.65% |
À propos de BBC
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Classe d’actifs Equity
Symbole boursier BBC
Date de création Dec 16, 2014
Fournisseur Virtus
Site web Page d’accueil du fonds
Échange NYSEArca
10 principaux titres 11.76% des actifs
| Nom | Symbole | Poids |
|---|---|---|
| First Tracks Biother... | TRAX | 1.67% |
| Mbx Biosciences Inc | MBX | 1.24% |
| Ataibeckley Inc | ATAI | 1.23% |
| Monopar Therapeutics... | MNPR | 1.21% |
| Definium Therapeutic... | DFTX | 1.18% |
| Xencor Inc | XNCR | 1.10% |
| Zenas Biopharma Inc | ZBIO | 1.06% |
| Uniqure Nv | QURE | 1.06% |
| Apogee Therapeutics ... | APGE | 1.02% |
| Vor Biopharma Inc Or... | VOR | 0.99% |
Dividendes Rendement du dividende 1.23%
| Ex-dividende | Montant | Date de paiement |
|---|---|---|
| Dec 22, 2025 | $0.6550 | n / A |
| Dec 20, 2024 | $0.2400 | n / A |
| Dec 20, 2023 | $0.0820 | n / A |
| Dec 20, 2017 | $0.2970 | n / A |
| Dec 21, 2015 | $0.1470 | n / A |
Page 1 de 2